NATALIE SOLIS: Open Payments
NPI 1063190072 · FLORENCE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$165 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $58 · 2025 $165
Food & beverage: $165
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| UCB, Inc. | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: ABILIFY MAINTENA, AUSTEDO XR, Fintepla, INGREZZA, Ozempic, Jornay PM.
Industry payments across AZ — which companies pay providers there.
